Merck Live Press Feed

AMM Announces The Doctors' Choice Awards Finalists: Over 4,600 MDs Vote for Best Journal Ads in AMM's Doctors' Choice Awards (1 Sep 2010 17:10:26)
AMM Announces The Doctors' Choice Awards Finalists: Over 4,600 MDs Vote for Best Journal Ads in AMM's Doctors' Choice Awards PR Newswire MOUNT LAUREL, N.J. , Sept. 1 /PRNewswire-USNewswire/ -- The Association of Medical Media...
Results From Investigator-Sponsored Trials Presented at SSIEM Conference (1 Sep 2010 13:00:00)
Results From Investigator-Sponsored Trials Presented at SSIEM Conference Kuvan Patients Show Improvements in Neurocognitive Functioning, Mood and Behavior PR Newswire NOVATO, Calif. , Sept. 1 /PRNewswire-FirstCall/ -- BioMarin...
US Educational Support Service for MS Community, MS LifeLines(R), Reaches Milestone of Servicing one Million In-bound Calls (1 Sep 2010 12:00:00)
US Educational Support Service for MS Community, MS LifeLines(R), Reaches Milestone of Servicing one Million In-bound Calls PR Newswire GENEVA , September 1, 2010 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt,...
MS LifeLines® Reaches Milestone of Servicing One Million In-Bound Calls (1 Sep 2010 12:00:00)
MS LifeLines® Reaches Milestone of Servicing One Million In-Bound Calls Educational Support Service for Multiple Sclerosis Community Provides a Voice at the Other End PR Newswire ROCKLAND, Mass. and NEW YORK , Sept. 1 /PRNewswire-FirstCall/...
Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 (31 Aug 2010 16:57:17)
Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 PR Newswire NEW YORK , Aug. 31 /PRNewswire/ Reportlinker.com announces that a new market research report is available...
Reportlinker Adds Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma (31 Aug 2010 16:45:29)
Reportlinker Adds Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma PR Newswire NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com...
Reportlinker Adds Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets (31 Aug 2010 16:15:04)
Reportlinker Adds Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets PR Newswire NEW YORK , Aug. 31 /PRNewswire/...
Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 (31 Aug 2010 15:59:16)
Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 PR Newswire NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: E7: The Outlook for Pharmaceuticals...
Reportlinker Adds Women's Infertility - Pipeline Assessment and Market Forecasts to 2017 (31 Aug 2010 15:58:21)
Reportlinker Adds Women's Infertility - Pipeline Assessment and Market Forecasts to 2017 PR Newswire NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:...
Hot US Stocks Alert: (RPC, Gilead Sciences, Inc., ArcSight Inc., Boston Merck & Co., Inc.) (30 Aug 2010 20:10:00)
( EMAILWIRE.COM , August 30, 2010 ) New York, NY-Radient Pharmaceuticals Corporation (AMEX:RPC) soared 33.87% to $0.830 on over 6.91 million shares after it announced the target market details for the domestic and international commercialization...
Critical Alerts for Exxon Mobil, Merck, Simon Property, CBS, and Republic Services Released by Seven Summits Research (30 Aug 2010 13:31:00)
Critical Alerts for Exxon Mobil, Merck, Simon Property, CBS, and Republic Services Released by Seven Summits Research PR Newswire CHICAGO , Aug. 30 /PRNewswire/ -- Seven Summits Research issues critical PriceWatch Alerts for XOM,...
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease (30 Aug 2010 13:00:00)
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease PR Newswire NOVATO, Calif. , Aug. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that...
Dr. Cameron Durrant named one of PharmaVOICE's 100 most inspiring people in the pharmaceutical industry for 2010 (30 Aug 2010 13:00:00)
Dr. Cameron Durrant named one of PharmaVOICE's 100 most inspiring people in the pharmaceutical industry for 2010 PR Newswire Recognized for leadership, innovation in annual ranking of top 100 industry professionals CALIFON,...
InfoLogix Positioned for Strategic Initiatives in Second Half of 2010 (26 Aug 2010 20:15:00)
InfoLogix Positioned for Strategic Initiatives in Second Half of 2010 PR Newswire HATBORO, Pa. , Aug. 26 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions...
4 out of 5 Physicians Online Visited Health Care Professional Sites in Q1 2010 (26 Aug 2010 16:42:14)
4 out of 5 Physicians Online Visited Health Care Professional Sites in Q1 2010 Medscape.com Ranks as Most-Visited Health-Related Destination by Physicians, Reaching More than Half of Doctors Online comScore Releases First in a Series...